Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Growth Hormone, Recombinant”

Showing 20 of 0 results

Not applicableStudy completedNCT00397592
What this trial is testing

Growth Hormone's Effect on Endothelial Progenitor Cells

Who this might be right for
Cardiovascular Disease
Vanderbilt University 18
Testing effectiveness (Phase 2)Ended earlyNCT07037420
What this trial is testing

ALXN2420 Versus Placebo in Combination With Somatostatin Analogs in Participants With Acromegaly

Who this might be right for
Acromegaly
Alexion Pharmaceuticals, Inc. 8
Post-approval studies (Phase 4)Study completedNCT01187550
What this trial is testing

Predictive Markers in Chinese Growth Hormone Deficiency (GHD) Children Treated With Saizen®

Who this might be right for
Dwarfism, Pituitary
Merck KGaA, Darmstadt, Germany 214
Not applicableStudy completedNCT01296425
What this trial is testing

To Assess the Level of Adherence of Subjects Receiving SAIZEN® Via Easypod™ in Austria

Who this might be right for
Growth Disorders
Merck KGaA, Darmstadt, Germany 50
Testing effectiveness (Phase 2)Study completedNCT03548415
What this trial is testing

Safety, Tolerability, and Efficacy of IONIS-GHR-LRx in Participants With Acromegaly Being Treated With Long-acting Somatostatin Receptor Ligands

Who this might be right for
Acromegaly
Ionis Pharmaceuticals, Inc. 43
Early research (Phase 1)Study completedNCT06331026
What this trial is testing

A Bioequivalence Study of Two Different PEG-rhGH Preparations.

Who this might be right for
Pediatric Growth Hormone Deficiency (PGHD)
Changchun GeneScience Pharmaceutical Co., Ltd. 87
Not applicableStudy completedNCT01421589
What this trial is testing

Growth Hormone Treatment on Phosphocreatine Recovery in Obesity

Who this might be right for
ObeseGrowth Hormone Secretion Abnormality
Massachusetts General Hospital 15
Not applicableStudy completedNCT01120977
What this trial is testing

Reference Values for Body Composition Parameters and IGF-I in the Adult NordiNet® International Outcome Study

Who this might be right for
Growth Hormone Deficiency
University of Aarhus 150
Not applicableStudy completedNCT03500913
What this trial is testing

Adipose Tissue and Serum Inflammation in GH Deficiency

Who this might be right for
Growth Hormone Deficiency
Columbia University 19
Large-scale testing (Phase 3)Study completedNCT01112865
What this trial is testing

Cross Over Convenience And Preference Study Of New Mark VII Compared To Genotropin Pen In Pediatric And Adult Subjects

Who this might be right for
Growth Hormone Deficiency
Pfizer 120
Large-scale testing (Phase 3)Ended earlyNCT02413138
What this trial is testing

Versartis Trial in Pre-pubertal Japanese Children With Growth Hormone Deficiency (GHD) to Assess Long-Acting Growth Hormone (Somavaratan, VRS-317)

Who this might be right for
Pediatric Growth Hormone DeficiencyGrowth Disorders
Versartis Inc. 41
Post-approval studies (Phase 4)Study completedNCT00458263
What this trial is testing

Biochemical Markers of Growth Response to Growth Hormone Treatment in Children With Idiopathic Short Stature

Who this might be right for
Idiopathic Short Stature
Rabin Medical Center 21
Not applicableStudy completedNCT02574793
What this trial is testing

Glycemic Fluctuations in Newly Diagnosed Growth Hormone-Secreting Pituitary Adenoma and Cushing Syndrome Subjects

Who this might be right for
Pituitary Adenoma
Huashan Hospital 60
Not applicableStudy completedNCT01400997
What this trial is testing

Level of Adherence of Subjects Receiving SAIZEN® Via Easypod™ in Czech Republic

Who this might be right for
Growth Disorders
Merck KGaA, Darmstadt, Germany 206
Testing effectiveness (Phase 2)UnknownNCT03189160
What this trial is testing

PEG-somatropin Injection to Treat Children of Turner Syndrome

Who this might be right for
Turner Syndrome
Changchun GeneScience Pharmaceutical Co., Ltd. 180
Not applicableEnded earlyNCT00646308
What this trial is testing

Assessment of Cardiovascular Risk Markers in Growth Hormone Deficient Patients With Nonsecreting Pituitary Adenomas

Who this might be right for
Growth Hormone DeficiencyPituitary Tumor
Columbia University 60
Not applicableStudy completedNCT01365351
What this trial is testing

Online Surveillance of Treatment of Children With Growth Hormone Deficiency With ZOMACTON

Who this might be right for
Growth Hormone Deficiency
Ferring Pharmaceuticals 1,034
Very early researchStudy completedNCT00929045
What this trial is testing

Growth Hormone and Insulin Growth Factor 1 Deficiencies in Children/Adolescents Following Traumatic Brain Injury: The Impact on Growth and Neuropsychological Development

Who this might be right for
Traumatic Brain Injury
University of Virginia 8
Early research (Phase 1)Study completedNCT01034202
What this trial is testing

Dose Study in Healthy Males Investigating Safety, Pharmacokinetics and Pharmacodynamics of NNC126-0083 Compared to Norditropin® SimpleXx®

Who this might be right for
Growth Hormone DisorderHealthy
Novo Nordisk A/S 56
Testing effectiveness (Phase 2)Active Not RecruitingNCT05382637
What this trial is testing

Growth Hormone in a Patient With a Dominant-Negative GHR Mutation

Who this might be right for
Growth Disorders
Children's National Research Institute 1
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation